METASTATIC UROTHELIAL CANCER
Clinical trials for METASTATIC UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy cocktail aims to fight advanced bladder cancer
Disease control OngoingThis large Phase 3 trial is testing whether adding the immunotherapy drugs durvalumab (with or without tremelimumab) to standard chemotherapy can help people with advanced bladder cancer that cannot be removed by surgery. Over 1,200 participants worldwide are receiving either che…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New hope for advanced bladder cancer: experimental drug combo enters late-stage trial
Disease control OngoingThis study tests an experimental drug called BT8009, alone or with another drug (pembrolizumab), in people with advanced urothelial cancer that has spread. The goal is to see if it works better than standard chemotherapy. About 375 participants will be enrolled, some who have not…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to treat bladder cancer without chemo
Disease control OngoingThis Phase 2 trial tests two new immunotherapy drugs, tobemstomig alone or with tiragolumab, against the standard drug atezolizumab. It includes 204 people with advanced bladder cancer who cannot have platinum chemotherapy. The main goal is to check safety and side effects.
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Immunotherapy duo aims to extend lives in advanced bladder cancer
Disease control OngoingThis large Phase 3 study tests whether combining two immunotherapy drugs (nivolumab and ipilimumab) or adding nivolumab to standard chemotherapy helps people with advanced bladder cancer live longer than chemotherapy alone. About 1,300 participants with untreated, inoperable or m…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC